These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4740962)

  • 61. Studies on the specificity toward aldehyde substrates and steady-state kinetics of xanthine oxidase.
    Morpeth FF
    Biochim Biophys Acta; 1983 May; 744(3):328-34. PubMed ID: 6687810
    [TBL] [Abstract][Full Text] [Related]  

  • 62. HEPATIC XANTHINE OXIDASE AND FERRITIN IRON IN THE DEVELOPING RAT.
    MAZUR A; CARLETON A
    Blood; 1965 Sep; 26():317-22. PubMed ID: 14332058
    [No Abstract]   [Full Text] [Related]  

  • 63. Multiple phases in the reduction of xanthine oxidase by substrates.
    Swann JC; Bray RC
    Eur J Biochem; 1972 Apr; 26(3):407-15. PubMed ID: 4338679
    [No Abstract]   [Full Text] [Related]  

  • 64. Effect of allopurinol (4-hydroxyprazolo(3,4-d)pyrimidine) on xanthine accumulation by milk xanthine oxidase in vitro.
    Jezewska MM
    Eur J Biochem; 1974 Jul; 46(2):361-5. PubMed ID: 4408204
    [No Abstract]   [Full Text] [Related]  

  • 65. A comparative study of the xanthine oxidase inhibitors allopurinol and oxipurinol in man.
    Chalmers RA; Krömer H; Scott JT; Watts RW
    Clin Sci; 1968 Oct; 35(2):353-62. PubMed ID: 5721238
    [No Abstract]   [Full Text] [Related]  

  • 66. Urinary-tract stones resulting from the excretion of oxypurinol.
    Landgrebe AR; Nyhan WL; Coleman M
    N Engl J Med; 1975 Mar; 292(12):626-7. PubMed ID: 1113742
    [No Abstract]   [Full Text] [Related]  

  • 67. Reduction of liver xanthine oxidase and iron storage proteins in rats fed excess zinc.
    Cox DH; Harris DL
    J Nutr; 1962 Dec; 78(4):415-8. PubMed ID: 14023550
    [No Abstract]   [Full Text] [Related]  

  • 68. Effect of reactive oxygen species on iron regulatory protein activity.
    Cairo G; Tacchini L; Recalcati S; Azzimonti B; Minotti G; Bernelli-Zazzera A
    Ann N Y Acad Sci; 1998 Jun; 851():179-86. PubMed ID: 9668619
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Milk xanthine oxidase type D (dehydrogenase) and type O (oxidase). Purification, interconversion and some properties.
    Battelli MG; Lorenzoni E; Stripe F
    Biochem J; 1973 Feb; 131(2):191-8. PubMed ID: 4352904
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Determination of the stoichiometry of electron uptake and the midpoint reduction potentials of milk xanthine oxidase at 25 degrees C by microcoulometry.
    Spence JT; Barber MJ; Siegel LM
    Biochemistry; 1982 Mar; 21(7):1656-61. PubMed ID: 6282314
    [No Abstract]   [Full Text] [Related]  

  • 71. Iron incorporation into ferritins: evidence for the transfer of monomeric Fe(III) between ferritin molecules and for the formation of an unusual mineral in the ferritin of Escherichia coli.
    Bauminger ER; Treffry A; Hudson AJ; Hechel D; Hodson NW; Andrews SC; Levi S; Nowik I; Arosio P; Guest JR
    Biochem J; 1994 Sep; 302 ( Pt 3)(Pt 3):813-20. PubMed ID: 7945207
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pralsetinib.
    Am J Health Syst Pharm; 2021 Jan; 78(1):1-3. PubMed ID: 33091114
    [No Abstract]   [Full Text] [Related]  

  • 73. Futibatinib.
    Am J Health Syst Pharm; 2023 Apr; 80(8):470-472. PubMed ID: 36807400
    [No Abstract]   [Full Text] [Related]  

  • 74. Larotrectinib in TRK fusion-positive cancers.
    Burki TK
    Lancet Oncol; 2018 Apr; 19(4):e187. PubMed ID: 29503244
    [No Abstract]   [Full Text] [Related]  

  • 75. Reply to Bazaz and Denning.
    Chamilos G; Lionakis MS; Kontoyiannis DP
    Clin Infect Dis; 2018 Jun; 67(1):157-159. PubMed ID: 29370370
    [No Abstract]   [Full Text] [Related]  

  • 76. [On catalytic reduction of 4-acylaminisoquinolines].
    Shiotani S; Sakai K; Misuhashi K
    Yakugaku Zasshi; 1967 May; 87(5):547-9. PubMed ID: 5624497
    [No Abstract]   [Full Text] [Related]  

  • 77. Correction to "Skeletal Editing of Pyrimidines to Pyrazoles by Formal Carbon Deletion".
    Bartholomew GL; Carpaneto F; Sarpong R
    J Am Chem Soc; 2023 Jan; 145(2):1472. PubMed ID: 36595505
    [No Abstract]   [Full Text] [Related]  

  • 78. Reduction of exogenous flavins and mobilization of iron from ferritin by isolated mitochondria.
    Ulvik RJ
    J Bioenerg Biomembr; 1983 Jun; 15(3):151-60. PubMed ID: 18251103
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes. Possible mechanism in inflammation diseases.
    Biemond P; van Eijk HG; Swaak AJ; Koster JF
    J Clin Invest; 1984 Jun; 73(6):1576-9. PubMed ID: 6327764
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The release of iron from horse spleen ferritin by reduced flavins.
    Sirivech S; Frieden E; Osaki S
    Biochem J; 1974 Nov; 143(2):311-5. PubMed ID: 4462557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.